1. Fibroblast Growth Factor 23 Level and Cardiovascular Parameters in Children with Chronic Kidney Disease
- Author
-
Ankur Singh, Vikas Agarwal, Rabindra N. Mishra, Gaurav Singh, Abhishek Abhinay, Om Prakash Mishra, Amitnandan D. Dwivedi, Rajniti Prasad, and S.P. Mishra
- Subjects
Fibroblast growth factor 23 ,medicine.medical_specialty ,Pulse Wave Analysis ,Significant negative correlation ,Carotid Intima-Media Thickness ,Left ventricular mass ,Risk Factors ,Internal medicine ,medicine ,Humans ,cardiovascular diseases ,Significant risk ,Renal Insufficiency, Chronic ,Child ,Pulse wave velocity ,business.industry ,Odds ratio ,medicine.disease ,Fibroblast Growth Factors ,Fibroblast Growth Factor-23 ,Pediatrics, Perinatology and Child Health ,cardiovascular system ,Cardiology ,Alkaline phosphatase ,business ,Kidney disease - Abstract
To find out the serum fibroblast growth factor 23 (FGF-23) levels in different grades of CKD, and the prevalence of abnormal left ventricular mass index (LVMI), carotid intima–medial thickness (cIMT), and central pulse wave velocity (cPWV) and the risk factors including FGF-23 for these abnormalities. Fifty-nine patients of CKD with G2 to G5, aged 2–18 y were included. The LVMI, cIMT, and cPWV were measured using standard techniques, and serum intact FGF-23 levels were estimated at enrollment. Median FGF-23 levels were significantly raised in all the grades of CKD than controls (p
- Published
- 2021
- Full Text
- View/download PDF